Abstract
RWD62 Dupixam: An SNDS (SYSTÈME NATIONAL DES DONNÉES DE SANTÉ) Study to Characterize Patients Treated with Dupilumab for Moderate-to-Severe Atopic Dermatitis in France
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have